Skip to content

Transcranial magnetic stimulation induced motor evoked potential in the expression of brain-derived neurotrophic factor BDNF, pathological pain and quality of life in patients with spinal cord injury

Transcranial magnetic stimulation induced motor evoked potential in the expression of brain-derived neurotrophic factor BDNF, pathological pain and quality of life in patients with spinal cord injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011706
Enrollment
Unknown
Registered
2017-06-20
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

observe group:Transcranial magnetic stimulation and Routine rehabilitation therapy
control group:Transcranial magnetic stimulation at very low threshold intensity and Routine rehabilitation therapy

Sponsors

Kunshan Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inpatients of spinal cord injury in Kunshan rehabilitation hospital and Suzhou science and technology city hospital were selected from July 2017 to December 2018. Inclusion criteria: all patients were confirmed by magnetic resonance imaging as C6-T1 segment spinal cord injury. Patients suffered from loss or disappearance of pain below the plane, or had neuropathic pain

Exclusion criteria

Exclusion criteria: All patients had no cardiac pacemaker, tumor and other magnetic stimulation contraindications

Design outcomes

Primary

MeasureTime frame
Short form McGillPain Questionnaire;

Secondary

MeasureTime frame
HAMD;HAMA;World Health Organization quality of life assessment instrument brief scale;

Countries

China

Contacts

Public ContactShi Jiajia

Kunshan Rehabilitation Hospital

707529535@qq.com+86 15262684771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026